RecensMedical, Inc. (KOSDAQ:394420)
29,650
-750 (-2.47%)
At close: Apr 28, 2026
RecensMedical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 987.51 | 5,296 | 2,571 | 9,402 |
Short-Term Investments | - | 5,000 | - | 7,032 |
Cash & Short-Term Investments | 987.51 | 10,296 | 2,571 | 16,434 |
Cash Growth | -90.41% | 300.46% | -84.35% | - |
Accounts Receivable | 3,085 | 2,474 | 3,093 | 37.4 |
Other Receivables | 349.29 | 209.66 | 217.33 | 146.68 |
Receivables | 3,435 | 2,684 | 3,310 | 184.08 |
Inventory | 3,673 | 3,945 | 6,312 | 4,590 |
Prepaid Expenses | 25.72 | 18.15 | 75.99 | 48.84 |
Other Current Assets | 279.36 | 166.77 | 184.59 | 1,546 |
Total Current Assets | 8,400 | 17,110 | 12,453 | 22,802 |
Property, Plant & Equipment | 3,320 | 2,547 | 2,313 | 2,370 |
Long-Term Investments | -0 | -0 | 0 | 0 |
Other Intangible Assets | 112.52 | 122.8 | 157.3 | 199.5 |
Other Long-Term Assets | 174.37 | 317.31 | 302.45 | 263.85 |
Total Assets | 12,007 | 20,097 | 15,226 | 25,635 |
Accounts Payable | 561.87 | 110.37 | 493.12 | 139.19 |
Accrued Expenses | 336.35 | 447.72 | 199.35 | 237.1 |
Current Portion of Long-Term Debt | 100 | 100 | 100 | 100.24 |
Current Portion of Leases | 256.36 | 170.7 | 160.24 | 288.34 |
Other Current Liabilities | 1,863 | 71,854 | 82,906 | 91,119 |
Total Current Liabilities | 3,117 | 72,682 | 83,859 | 91,884 |
Long-Term Debt | 100 | 199.99 | 299.99 | 399.76 |
Long-Term Leases | 348.37 | 146.92 | 218.39 | 184.75 |
Pension & Post-Retirement Benefits | 1,137 | 990.1 | 807.64 | 503.87 |
Other Long-Term Liabilities | 326.74 | 322.58 | 318.45 | 270.37 |
Total Liabilities | 5,030 | 74,342 | 85,503 | 93,242 |
Common Stock | 4,704 | 1,719 | 1,694 | 1,656 |
Additional Paid-In Capital | 115,904 | 3,377 | 2,656 | 1,274 |
Retained Earnings | -116,588 | -97,584 | -89,751 | -82,073 |
Comprehensive Income & Other | 2,957 | 1,925 | 1,429 | 846.72 |
Total Common Equity | 6,977 | -90,563 | -83,973 | -78,297 |
Shareholders' Equity | 6,977 | -54,245 | -70,277 | -67,607 |
Total Liabilities & Equity | 12,007 | 20,097 | 15,226 | 25,635 |
Total Debt | 804.72 | 617.61 | 778.61 | 973.09 |
Net Cash (Debt) | 182.79 | 9,679 | 1,793 | 15,460 |
Net Cash Growth | -98.11% | 439.95% | -88.41% | - |
Net Cash Per Share | 27.63 | 2828.22 | 540.42 | 4681.06 |
Filing Date Shares Outstanding | 9.42 | 3.44 | 3.39 | 3.3 |
Total Common Shares Outstanding | 9.42 | 3.44 | 3.39 | 3.3 |
Working Capital | 5,283 | -55,572 | -71,406 | -69,081 |
Book Value Per Share | 740.33 | -26343.82 | -24782.21 | -23706.50 |
Tangible Book Value | 6,864 | -90,686 | -84,130 | -78,497 |
Tangible Book Value Per Share | 728.39 | -26379.54 | -24828.63 | -23766.90 |
Land | 220.33 | 220.33 | 220.33 | 220.33 |
Buildings | 1,297 | 1,299 | 1,291 | 1,290 |
Machinery | 1,850 | 1,090 | 725.97 | 489.04 |
Construction In Progress | - | 45.29 | - | 32.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.